Spots Global Cancer Trial Database for imatinib mesylate (gleevec)
Every month we try and update this database with for imatinib mesylate (gleevec) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Preoperative and Postoperative Imatinib Mesylate Study in Patients With c-Kit Positive GIST | NCT00500188 | Gastrointestina... | Imatinib Mesyla... | - | M.D. Anderson Cancer Center | |
Therapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib Mesylate | NCT00038675 | Chronic Myelomo... Chronic Myeloid... Polycythemia Ve... Hypereosinophil... Mastocytosis | Imatinib Mesyla... | - | M.D. Anderson Cancer Center | |
PTK 787 and Gleevec in Patients With AML, AMM, and CML-BP | NCT00088231 | Acute Myelogeno... Agnogenic Myelo... Chronic Myeloge... | Imatinib Mesyla... PTK 787 (vatala... | 15 Years - | M.D. Anderson Cancer Center | |
Therapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib Mesylate | NCT00038675 | Chronic Myelomo... Chronic Myeloid... Polycythemia Ve... Hypereosinophil... Mastocytosis | Imatinib Mesyla... | - | M.D. Anderson Cancer Center | |
Study of Lonafarnib and Gleevec in Chronic Myelogenous Leukemia | NCT00047502 | Chronic Myeloge... | Lonafarnib (SCH... Imatinib Mesyla... | 16 Years - | M.D. Anderson Cancer Center |